Lexaria Bioscience Corp (LEXX)
3.58
+0.04
(+1.13%)
USD |
NASDAQ |
May 09, 16:00
3.70
+0.12
(+3.35%)
After-Hours: 20:00
Lexaria Bioscience Price to Book Value: 7.074 for May 9, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 09, 2024 | 7.074 |
May 08, 2024 | 6.995 |
May 07, 2024 | 6.778 |
May 06, 2024 | 6.738 |
May 03, 2024 | 6.185 |
May 02, 2024 | 5.928 |
May 01, 2024 | 6.897 |
April 30, 2024 | 6.106 |
April 29, 2024 | 4.861 |
April 26, 2024 | 4.644 |
April 25, 2024 | 4.328 |
April 24, 2024 | 4.347 |
April 23, 2024 | 4.426 |
April 22, 2024 | 4.476 |
April 19, 2024 | 4.347 |
April 18, 2024 | 4.446 |
April 17, 2024 | 4.624 |
April 16, 2024 | 4.565 |
April 15, 2024 | 3.932 |
April 12, 2024 | 4.189 |
April 11, 2024 | 4.96 |
April 10, 2024 | 5.256 |
April 09, 2024 | 5.336 |
April 08, 2024 | 5.752 |
April 05, 2024 | 5.927 |
Date | Value |
---|---|
April 04, 2024 | 6.199 |
April 03, 2024 | 6.626 |
April 02, 2024 | 6.743 |
April 01, 2024 | 6.646 |
March 28, 2024 | 7.054 |
March 27, 2024 | 7.209 |
March 26, 2024 | 7.365 |
March 25, 2024 | 7.676 |
March 22, 2024 | 6.743 |
March 21, 2024 | 6.684 |
March 20, 2024 | 7.190 |
March 19, 2024 | 7.773 |
March 18, 2024 | 6.607 |
March 15, 2024 | 7.578 |
March 14, 2024 | 7.481 |
March 13, 2024 | 8.550 |
March 12, 2024 | 8.122 |
March 11, 2024 | 11.87 |
March 08, 2024 | 10.45 |
March 07, 2024 | 9.499 |
March 06, 2024 | 8.511 |
March 05, 2024 | 6.421 |
March 04, 2024 | 5.699 |
March 01, 2024 | 5.547 |
February 29, 2024 | 6.554 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9326
Minimum
May 10 2023
29.34
Maximum
May 10 2019
6.978
Average
3.385
Median
Jun 07 2021
Price to Book Value Benchmarks
Aurinia Pharmaceuticals Inc | 1.957 |
Sunshine Biopharma Inc | 0.0433 |
Acasti Pharma Inc | 0.4011 |
Edesa Biotech Inc | 2.450 |
Xenon Pharmaceuticals Inc | 3.451 |
Price to Book Value Related Metrics
PS Ratio | 79.68 |
Price | 3.58 |
Earnings Yield | -18.99% |
Market Cap | 46.13M |